Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia
- 1 April 2011
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 19 (4), 484-497
- https://doi.org/10.1016/j.ccr.2011.02.008
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemiaThe Journal of Experimental Medicine, 2010
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulationNature Immunology, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- MN1, a novel player in human AMLBlood Cells, Molecules, and Diseases, 2007
- NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growthProceedings of the National Academy of Sciences of the United States of America, 2006
- Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture–on-chip (4C)Nature Genetics, 2006
- c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphomaGenes & Development, 2006
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001